10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2012 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2012 | Dec 31, 2011 | |
| Current Assets: | ||
| Cash and cash equivalents | $ 10,802,163 | 6,812,820 |
| Investments, primarily bank time deposits and U.S. treasury bills | 4,371,821 | 1,284,539 |
| Trade receivables, less allowances of - 2012: $405,921; 2011: $420,579; 2010: $388,564 | 7,612,860 | 7,683,920 |
| Inventories: | ||
| Finished products | 2,345,455 | 2,220,527 |
| Work in process | 628,874 | 432,358 |
| Materials | 817,984 | 631,364 |
| Total inventories | 3,792,313 | 3,284,249 |
| Deferred income taxes | 2,986,216 | 2,700,540 |
| Other prepaid expenses and receivables | 1,757,210 | 2,002,706 |
| Total Current Assets | 31,322,583 | 23,768,774 |
| Investments | 273,595 | 378,225 |
| Property and Equipment, at Cost: | ||
| Land | 604,462 | 633,917 |
| Buildings | 4,259,240 | 4,467,387 |
| Equipment | 13,110,833 | 12,216,388 |
| Construction in progress | 954,352 | 698,873 |
| Property and Equipment, at Cost | 18,928,887 | 18,016,565 |
| Less: accumulated depreciation and amortization | 10,865,840 | 10,142,610 |
| Net Property and Equipment | 8,063,047 | 7,873,955 |
| Intangible Assets, net of amortization | 8,588,285 | 9,989,636 |
| Goodwill | 15,774,127 | 15,705,380 |
| Deferred Income Taxes and Other Assets | 3,213,307 | 2,560,923 |
| Total Assets | 67,234,944 | 60,276,893 |
| Liabilities and Shareholders' Investment | ||
| Current Liabilities: | ||
| Short-term borrowings | 2,081,839 | 2,347,859 |
| Trade accounts payable | 1,796,990 | 1,721,127 |
| Salaries, wages and commissions | 1,427,765 | 1,260,121 |
| Other accrued liabilities | 6,787,995 | 7,854,994 |
| Dividends payable | 221,340 | 754,284 |
| Income taxes payable | 655,424 | 514,947 |
| Current portion of long-term debt | 308,823 | 1,026,896 |
| Total Current Liabilities | 13,280,176 | 15,480,228 |
| Long-term Debt | 18,085,302 | 12,039,822 |
| Post-employment Obligations and Other Long-term Liabilities | 9,056,234 | 8,230,698 |
| Commitments and Contingencies | ||
| Shareholders' Investment: | ||
| Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | ||
| Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2012: 1,675,930,484; 2011: 1,638,870,201; 2010: 1,619,689,876 | 11,754,552 | 9,817,134 |
| Common shares held in treasury, at cost - Shares: 2012: 99,262,992; 2011: 68,491,382; 2010: 72,705,928 | (5,590,909) | (3,687,478) |
| Earnings employed in the business | 24,150,996 | 20,907,362 |
| Accumulated other comprehensive income (loss) | (3,593,678) | (2,597,185) |
| Total Abbott Shareholders' Investment | 26,720,961 | 24,439,833 |
| Noncontrolling Interests in Subsidiaries | 92,271 | 86,312 |
| Total Shareholders' Investment | 26,813,232 | 24,526,145 |
| Total Liabilities and Shareholders' Investment | 67,234,944 | 60,276,893 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2012 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |